IC
ICL.US ICL Israel Chemicals Ltd
- Market cap
- USD 6.03B
- P/E
- 18.1x
- P/B
- 0.94x
- ROE
- 8.2%
- Dividend yield
- 3.72%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ICL.US undervalued?
Graham numberICL.US trades 13.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ICL Israel Chemicals Ltd fundamental analysis
No fundamental analysis for ICL Israel Chemicals Ltd yet.
ICL Israel Chemicals Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ICL Israel Chemicals Ltd
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various grades of potash, salt, magnesium chloride, and magnesia products; and produces an…
Full company profileICL Israel Chemicals Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ICL Israel Chemicals Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 5.36B | 5.42B | 5.56B | 5.27B | 5.04B | 6.96B | 10.0B | 7.54B | 6.84B | 7.15B | 8.09B |
| Gross Profit | 1.66B | 1.67B | 1.85B | 1.82B | 1.49B | 2.61B | 5.03B | 2.67B | 2.26B | 2.19B | 2.56B |
| Operating Income | -3.00M | 629M | 1.52B | 756M | 202M | 1.21B | 3.52B | 1.14B | 775M | 703M | 976M |
| EBITDA | 413M | 992M | 1.98B | 1.18B | 634M | 1.69B | 4.04B | 1.67B | 1.38B | 1.35B | 1.81B |
| Net Income | -122M | 364M | 1.24B | 475M | 11.0M | 783M | 2.16B | 647M | 407M | 226M | 511M |
| EPS | -0.10 | 0.29 | 0.97 | 0.37 | 0.01 | 0.61 | 1.67 | 0.50 | 0.32 | 0.18 | 0.40 |
| Balance Sheet | |||||||||||
| Total Assets | 8.55B | 8.71B | 8.75B | 9.17B | 9.66B | 11.1B | 11.8B | 11.6B | 11.3B | 12.4B | 13.3B |
| Total Liabilities | 5.89B | 5.78B | 4.83B | 5.11B | 5.58B | 6.34B | 6.04B | 5.59B | 5.33B | 6.17B | 6.75B |
| Shareholders' Equity | 2.57B | 2.86B | 3.78B | 3.93B | 3.93B | 4.53B | 5.46B | 5.77B | 5.72B | 5.98B | 6.22B |
| Cash & Short-term Investments | 116M | 173M | 213M | 191M | 314M | 564M | 508M | 592M | 442M | 496M | 637M |
| Total Debt | 3.38B | 3.21B | 2.43B | 2.60B | 2.73B | 3.01B | 2.82B | 2.69B | 2.29B | 2.76B | 3.26B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 966M | 847M | 620M | 992M | 804M | 1.07B | 2.03B | 1.60B | 1.36B | 954M | 968M |
| Capital Expenditure | 632M | 457M | 572M | 576M | 626M | 611M | 747M | 780M | 713M | 824M | 696M |
| Free Cash Flow | 334M | 390M | 48.0M | 416M | 178M | 454M | 1.28B | 815M | 650M | 130M | 272M |
| Ratios | |||||||||||
| ROE | -4.7% | 12.7% | 32.8% | 12.1% | 0.3% | 17.3% | 39.5% | 11.2% | 7.1% | 3.8% | 8.2% |
| ROA | -1.4% | 4.2% | 14.2% | 5.2% | 0.1% | 7.1% | 18.4% | 5.6% | 3.6% | 1.8% | 3.8% |
| Net Profit Margin | -2.3% | 6.7% | 22.3% | 9.0% | 0.2% | 11.3% | 21.6% | 8.6% | 5.9% | 3.2% | 6.3% |
| Debt to Equity | 1.31x | 1.12x | 0.64x | 0.66x | 0.70x | 0.67x | 0.52x | 0.47x | 0.40x | 0.46x | 0.52x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
ICL Israel Chemicals Ltd dividends
- Dividend yield
- 3.72%
- Forward dividend
- 0.20 USD
- Payout ratio
- 99.1%
- Ex-dividend date
- Dec 2, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 224M | 0.17 | 99.1% |
| 2024 | USD 308M | 0.24 | 75.7% |
| 2023 | USD 489M | 0.38 | 75.6% |
| 2022 | USD 1.17B | 0.90 | 54.0% |
| 2021 | USD 276M | 0.21 | 35.2% |
| 2020 | USD 118M | 0.09 | 1,072.7% |
| 2019 | USD 273M | 0.21 | 57.5% |
| 2018 | USD 241M | 0.19 | 19.4% |
| 2017 | USD 237M | 0.19 | 65.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ICL Israel Chemicals Ltd
- Insiders 43.98%
- Institutions 36.10%
- Public & others 19.92%
- Shares outstanding 1.29B
- Free float 723M
Top funds holding ICL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard Total Intl Stock Index Inv | 10.7M | 0.83% | +1.35% | Sep 2026 |
| State Street® SPDR® S&P® Glb Ntrl Rs ETF | 8.26M | 0.64% | +0.14% | Oct 2026 |
| Northern Trust MstarGlblUpstmNatrlResETF | 8.11M | 0.63% | 0.00% | Oct 2026 |
| Vanguard Developed Markets Index Admiral | 7.10M | 0.55% | 0.00% | Sep 2026 |
| iShares Core MSCI EAFE ETF | 5.89M | 0.46% | 0.00% | Oct 2026 |
| Fidelity International Index | 2.81M | 0.22% | +1.12% | Sep 2026 |
| iShares MSCI EAFE ETF | 2.66M | 0.21% | 0.00% | Oct 2026 |
| iShares MSCI EAFE Value ETF | 2.33M | 0.18% | 0.00% | Oct 2026 |
| Schwab International Equity ETF | 1.72M | 0.13% | 0.00% | Oct 2026 |
| Vanguard FTSE All-Wld ex-US ETF | 1.72M | 0.13% | 0.00% | Sep 2026 |
| Schwab Fundamental International Eq ETF | 1.70M | 0.13% | 0.00% | Oct 2026 |
| VanEck Agribusiness ETF | 1.66M | 0.13% | 0.00% | Oct 2026 |
| iShares MSCI Israel ETF | 1.53M | 0.12% | 0.00% | Oct 2026 |
| Stt Strt®SPDR®S&PKenshoNwEcosComposETF | 1.50M | 0.12% | +0.08% | Oct 2026 |
| Fidelity Series Global ex US Index | 1.39M | 0.11% | 0.00% | Aug 2026 |
| Nuveen International Eq Idx R6 | 1.20M | 0.09% | 0.00% | Sep 2026 |
| State Street® SPDR® Ptf Dev Wld exUS ETF | 1.11M | 0.09% | 0.00% | Oct 2026 |
| iShares Core MSCI World ETF USD Acc | 1.10M | 0.09% | 0.00% | Oct 2026 |
| iShares Core MSCI Intl Dev Mkts ETF | 1.06M | 0.08% | 0.00% | Oct 2026 |
| iShares Core MSCI Total Intl Stk ETF | 1.06M | 0.08% | 0.00% | Oct 2026 |
Top institutions holding ICL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Altshuler Shaham Ltd | 24.0M | 1.86% | +7.61% | Jun 2026 |
| Vanguard Capital Management, LLC | 20.9M | 1.62% | +1.17% | Jun 2026 |
| Clal Insurance Enterprises Holdings Ltd | 19.8M | 1.54% | -10.11% | Jun 2026 |
| Y.D. More Investments Ltd | 19.5M | 1.51% | -0.61% | Jun 2026 |
| Phoenix Financial Ltd | 15.6M | 1.21% | +1.73% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 9.84M | 0.76% | +31.70% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 6.46M | 0.50% | +1.15% | Jun 2026 |
| BlackRock Inc | 5.73M | 0.44% | +26.77% | Jun 2026 |
| The Goldman Sachs Group Inc | 5.48M | 0.42% | +81.65% | Jun 2026 |
| Legal & General Group PLC | 4.49M | 0.35% | +3.26% | Jun 2026 |
| Swiss National Bank | 2.54M | 0.20% | -0.31% | Sep 2026 |
| Harel Insurance Invests & Fin Srvcs Ltd | 1.91M | 0.15% | 0.00% | Jun 2026 |
| Nuveen, LLC | 1.84M | 0.14% | +0.06% | Jun 2026 |
| JPMorgan Chase & Co | 1.81M | 0.14% | +67.96% | Jun 2026 |
| Deutsche Bank AG | 1.80M | 0.14% | +11.93% | Jun 2026 |
| VANGUARD ASSET MANAGEMENT Ltd | 1.65M | 0.13% | +11.07% | Jun 2026 |
| State Street Corp | 1.47M | 0.11% | 0.00% | Jun 2026 |
| Bank of New York Mellon Corp | 1.34M | 0.10% | -1.06% | Jun 2026 |
| Grantham, Mayo, Van Otterloo & Co., LLC | 1.31M | 0.10% | -9.76% | Jun 2026 |
| Bank of America Corp | 1.23M | 0.10% | +8.03% | Jun 2026 |
ICL Israel Chemicals Ltd company profile
- Company name
- ICL Israel Chemicals Ltd
- Ticker
- ICL.US
- ISIN
- IL0002810146
- Exchange
- USA Stocks
- Listed since
- Sep 24, 2014
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 12,000
- Fiscal year end
- December
- Address
- Landmark Tower, Tel Aviv-Yafo, Israel, 6473309
- Phone
- 972 3 684 4459
- Website
- icl-group.com
About ICL Israel Chemicals Ltd
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment produces and sells potash, salt, magnesium, electricity, and magnesium alloys; as well as chlorine and sylvinite. The Phosphate segment uses phosphate commodity products to produce specialty products; sells phosphate-based fertilizers, as well as sulphuric and green phosphoric acid, and phosphate fertilizers; and offers phosphate salts and acids. It also develops and produces functional food ingredients and phosphate additives. The Growing Solutions segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water-soluble specialty, and controlled-release fertilizers, as well as secondary nutrients, bio-stimulants, soil conditioners, seed treatment products, and adjuvants. It also offers digital platforms and technological solutions for farmers and agronomists. The company serves pharmaceutical, food, oil and gas, de-icing, building and construction, oral care, paints and coatings, energy storage, water treatment, electronics, automotive, agriculture, textiles, tire manufacturing, and healthcare industries, as well as power plants and battery producers. It sells its products through marketing companies, agents, and distributors. The company was formerly known as Israel Chemicals Ltd. and changed its name to ICL Group Ltd in May 2020. The company was incorporated in 1968 and is headquartered in Tel Aviv-Yafo, Israel.
ICL Israel Chemicals Ltd management
10- Mr. Yoav DoppeltExecutive Chairman · born 1969
- Mr. Elad AharonsonPresident & CEO · born 1974
- Mr. Uri PerelmanExecutive VP, Chief Corporate Business Development Officer & Member of Advisory Board · born 1981
- Mr. Asaf Alperovitz CPAChief Financial Officer · born 1970
- Dr. Anantha N. DesikanExecutive VP and Chief Innovation & Technology Officer · born 1969
- Ms. Alegra KilsteinExecutive VP & Global Chief Information Officer
- Ms. Peggy Reilly TharpVice President of Global Investor Relations
- Ms. Aya LandmanVP, Chief Compliance Officer & Corporate Secretary
- Ms. Maya GrinfeldSenior Vice President of Global Marketing & Communications · born 1976
- Ms. Ilana FahimaExecutive VP & Chief People Officer · born 1966